Đang chuẩn bị liên kết để tải về tài liệu:
Drug repurposing: Ibrutinib exhibits immunosuppressive potential in organ transplantation

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG

Long-term administration of classic immunosuppressants can induce severe adverse effects. The development of novel immunosuppressants confronts great challenges and opportunities. Ibrutinib, an approved drug for B-cell lineages and chronic graft versus host disease (cGVHD), exhibits immunosuppressive efficacy in autoimmune diseases. | Drug repurposing: Ibrutinib exhibits immunosuppressive potential in organ transplantation

TÀI LIỆU LIÊN QUAN

Exploiting large-scale drug-protein interaction information for computational drug repurposing

Large-scale detection of drug off-targets: Hypotheses for drug repurposing and understanding side-effects

SPIDR: Small-molecule peptide-influenced drug repurposing

Synthetic repurposing of drugs against hypertension: A datamining method based on association rules and a novel discrete algorithm

Drug voyager: A computational platform for exploring unintended drug action

The assessment of efficient representation of drug features using deep learning for drug repositioning

A two-tiered unsupervised clustering approach for drug repositioning through heterogeneous data integration

Visualizing the dynamics of genetic profile in breast cancer treatment: A better way to explain why a drug could be repurposed: A riview

Comparative assessment of strategies to identify similar ligand-binding pockets in proteins

Drug repurposing to target Ebola virus replication and virulence using structural systems pharmacology
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.